A new investment framework is one of several issues expected to dominate discussions within the Global Fund Committee on HIV and AIDS in the coming months. The others: cost of treatment, unit costs, drug optimization and inclusion of communities.
The group forms part of a trio of committees — one for each disease — launched this month by the Global Fund to Fight AIDS, Tuberculosis and Malaria. The action is designed to better engage with partners as prescribed by the fund’s new strategy.
The committee on TB met June 11. On June 18, it was the HIV and AIDS committee’sturn.
Debrework Zewdie, deputy executive director of the Global Fund, clarified that the body does not constitute a technical committee but aims to “advise the Global Fund on how the war [on the AIDS] is going.”
Gabriel Jaramillo, the fund’s general manager, joined Zewdie in the meeting. Craig McClure, chief of UNICEF’s HIV and AIDS section, and Bernhard Schwartländer, director of evidence, strategy and results at the Joint United Nations Program on HIV/AIDS, were also present.
Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.